Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 30, 2015
Merck expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
read more
Thursday, September 05, 2013
Merck, known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines ...
read more
Wednesday, December 04, 2024
Merck announced that the National Medical Products Administration (NMPA) in China has approved WELIREG® (belzutifan), for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (...
read more
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more
Wednesday, January 05, 2022
Dipharma Francis, a global CDMO and a manufacturer of APIs and intermediates for generic and contract manufacturing markets, is announced that Kalexsyn, Inc., a Michigan corporation acquired in 2018, has been merged into its 100% owner, Dipharma Inc....
read more
INC Research Holdings and inVentiv Health announced their Boards of Directors have approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock transaction.
read more
Wednesday, April 12, 2023
Meridian Medical Technologies, a Kindeva Drug Delivery Company, a global CDMO focused on drug-device combination products, announced it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next ...
read more
Thursday, September 20, 2018
Merrimack Pharmaceuticals has received a $5 million milestone payment from Shire, triggered by the sale of Onivyde in the first major non-European, non-Asian country.
read more
Wednesday, February 03, 2016
Mersana Therapeutics and Takeda Pharmaceutical Company have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada.
read more
ProBioGen AG and Merus N.V. jointly announced that Merus has signed a commercial multi-product license agreement for ProBioGen’s GlymaxX® ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) enhancement technology.
read more
Meso Scale Diagnostics has received 510(k) clearance from the FDA for its conventional CRP assay for IVD use in the United States.
read more
metabion has increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives thereof to support the rising demand in Europe and worldwide.
read more
Metabolon now offers more than 150 qualified and/or validated targeted biochemical assays for pharmaceutical and biotechnology R&D.
read more
Metabolon, Inc. has entered into an agreement with InnVentis Ltd. to apply metabolomics in individuals with chronic inflammatory diseases, such as rheumatoid arthritis. InnVentis aims to bring together multi-omics technologies with clinical data and ...
read more
Wednesday, February 13, 2019
Fresenius Kabi announced the immediate availability in the United States of Methocarbamol Injection, USP in a 100 mg per mL 10 mL vial presentation.
read more